Abbott Laboratories Operating Expense Breakdown

History

Date	Selling, General, and Administrative	Research and Development	Amortization
Sep 30, 2024	11.51B	2.80B	1.89B
Jun 30, 2024	11.34B	2.75B	1.92B
Mar 31, 2024	11.15B	2.77B	1.95B
Dec 31, 2023	10.95B	2.74B	1.97B
Sep 30, 2023	11.20B	2.77B	1.98B
Jun 30, 2023	11.21B	2.88B	1.98B
Mar 31, 2023	11.22B	2.85B	1.99B
Dec 31, 2022	11.25B	2.89B	2.01B
Sep 30, 2022	11.32B	2.93B	2.03B
Jun 30, 2022	11.36B	2.82B	2.05B
Mar 31, 2022	11.33B	2.79B	2.05B
Dec 31, 2021	11.32B	2.74B	2.05B
Sep 30, 2021	10.85B	2.68B	2.04B
Jun 30, 2021	10.38B	2.59B	2.03B
Mar 31, 2021	9.93B	2.50B	2.08B
Dec 31, 2020	9.70B	2.42B	2.13B
Sep 30, 2020	9.54B	2.32B	2.11B
Jun 30, 2020	9.68B	2.33B	2.08B
Mar 31, 2020	9.84B	2.35B	2.01B
Dec 31, 2019	9.77B	2.44B	1.94B

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.